CMS vs JAZZ · P/E 20, $22.42B cap vs P/E 1988, rev $4.07B
CMS Energy Corporation (CMS) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
CMS does not have a complete income-statement cache yet.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
CMS currently screens at market cap $22.42B and trailing P/E 20.1. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the CMS and JAZZ stock pages for the full models.
Not investment advice.